Martiny-Baron G - Search Results

1

Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity.

Chrencik JE, Brooun A, Recht MI, Kraus ML, Koolpe M, Kolatkar AR, Bruce RH, Martiny-Baron G, Widmer H, Pasquale EB, Kuhn P. Chrencik JE, et al. Structure. 2006 Feb;14(2):321-30. doi: 10.1016/j.str.2005.11.011. Structure. 2006. PMID: 16472751 Free article.

2

Inhibition of tumor growth and angiogenesis by soluble EphB4.

Martiny-Baron G, Korff T, Schaffner F, Esser N, Eggstein S, Marmé D, Augustin HG. Martiny-Baron G, et al. Neoplasia. 2004 May-Jun;6(3):248-57. doi: 10.1593/neo.3457. Neoplasia. 2004. PMID: 15153337 Free PMC article.

3

Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness.

Korff T, Kimmina S, Martiny-Baron G, Augustin HG. Korff T, et al. FASEB J. 2001 Feb;15(2):447-57. doi: 10.1096/fj.00-0139com. FASEB J. 2001. PMID: 11156960

4

VEGF-mediated tumour angiogenesis: a new target for cancer therapy.

Martiny-Baron G, Marmé D. Martiny-Baron G, et al. Curr Opin Biotechnol. 1995 Dec;6(6):675-80. doi: 10.1016/0958-1669(95)80111-1. Curr Opin Biotechnol. 1995. PMID: 8527839 Review.

5

Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.

Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marmé D. Siemeister G, et al. Cancer Res. 1996 May 15;56(10):2299-301. Cancer Res. 1996. PMID: 8625303

6

The alpha-helical domain near the amino terminus is essential for dimerization of vascular endothelial growth factor.

Siemeister G, Marmé D, Martiny-Baron G. Siemeister G, et al. J Biol Chem. 1998 May 1;273(18):11115-20. doi: 10.1074/jbc.273.18.11115. J Biol Chem. 1998. PMID: 9556597 Free article.

7

The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities.

Siemeister G, Martiny-Baron G, Marmé D. Siemeister G, et al. Cancer Metastasis Rev. 1998 Jun;17(2):241-8. doi: 10.1023/a:1006027124696. Cancer Metastasis Rev. 1998. PMID: 9770121 Review. No abstract available.

8

Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.

Siemeister G, Schirner M, Weindel K, Reusch P, Menrad A, Marmé D, Martiny-Baron G. Siemeister G, et al. Cancer Res. 1999 Jul 1;59(13):3185-91. Cancer Res. 1999. PMID: 10397264

9

Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats.

Fiedler U, Krissl T, Koidl S, Weiss C, Koblizek T, Deutsch U, Martiny-Baron G, Marmé D, Augustin HG. Fiedler U, et al. J Biol Chem. 2003 Jan 17;278(3):1721-7. doi: 10.1074/jbc.M208550200. Epub 2002 Nov 9. J Biol Chem. 2003. PMID: 12427764 Free article.

10

Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis.

Kolch W, Martiny-Baron G, Kieser A, Marmé D. Kolch W, et al. Breast Cancer Res Treat. 1995;36(2):139-55. doi: 10.1007/BF00666036. Breast Cancer Res Treat. 1995. PMID: 8534863 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters